Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

Novartis aims for 10 blockbuster launches by 2020

Novartis aims for 10 blockbuster launches by 2020

On the downside, revenues from post-patent expiry cancer drug Glivec continued to decline (down 20% to $1.56bn).

Biopharma's Future: Made in China

Biopharma's Future: Made in China Novartis’ leukaemia treatment Glivec.

Novartis gets speedy reviews for new Kymriah filings

Novartis gets speedy reviews for new Kymriah filings as Glivec (imatinib) are succumbing to generic competition.

Novartis Oncology head Bruno Strigini to retire

Novartis Oncology head Bruno Strigini to retire He has navigated the business unit through the Gleevec patent expiration and has led the successful integration of the GSK Oncology Product Portfolio acquired in 2015.

Novartis' orphan drug Tasigna wins EU expanded indication

Novartis' orphan drug Tasigna wins EU expanded indication Gilvec/Gleevec (imatinib).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics